This article provides a comprehensive framework for the validation of biosensors targeting metabolites, crucial biomarkers in medical diagnostics, drug development, and personalized medicine.
This article provides a systematic comparison of constitutive and inducible promoter systems, essential tools for controlling gene expression in synthetic biology and biopharmaceutical development.
This article provides a comprehensive evaluation of contemporary genome editing technologies, including CRISPR-Cas systems, TALENs, and base editors, for synthetic biology and therapeutic applications.
This article provides a comprehensive analysis of the performance of metabolic pathway optimization methods, tailored for researchers, scientists, and drug development professionals.
The adoption of synthetic data in computational biology is accelerating, offering solutions to data scarcity, privacy constraints, and the need for robust benchmark studies.
This article provides a comprehensive comparative analysis of the five generations of Chimeric Antigen Receptor T-cell (CAR-T) therapies, from foundational concepts to cutting-edge innovations.
Differential abundance (DA) analysis is a cornerstone of microbiome research, essential for identifying microbial biomarkers linked to health, disease, and environmental outcomes.
Actinobacteria are prolific producers of bioactive natural products, yet their low production titers and silent biosynthetic gene clusters (BGCs) present major challenges for drug development and industrial application.
This article addresses the critical challenge of circuit failure in complex biological systems, a central problem in developing treatments for neuropsychiatric and neurological disorders.
This article provides a detailed exploration of CRISPR interference (CRISPRi) as a powerful tool for the precise, multi-level regulation of metabolic pathways in both bacterial and eukaryotic systems.